Integrion Automation Builds on Its Medical Device Capabilities to Support Validated, Traceable Production

Integrion Automation provides validated, traceable automation solutions for medical device manufacturers, helping improve quality, compliance, and flexibility in regulated production environments. Its GAMP 5-based approach, validation services, advanced inspection and assembly technologies, and lifecycle support help manufacturers reduce risk while maintaining audit-ready operations.

Researchers Gain Faster Access to Complex DNA as Integrated DNA Technologies and Ansa Biotechnologies Expand Ordering Platform

Integrated DNA Technologies (IDT) and Ansa Biotechnologies expand partnership, making it easier for researchers to access longer, more complex DNA.

NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier

Pharmaceutical industry leader brings more than 20 years of global drug development, regulatory strategy and portfolio leadership experience across AbbVie, Merck KGaA, AstraZeneca and Abivax.

1upHealth Launches 1up Clinical Connect to Help Payers Strengthen HEDIS Scores, Star Ratings, and Financial Performance with Continuous Clinical Data

Watchmaker Genomics Expands Boulder Manufacturing Campus to More Than Double Manufacturing Capacity

Watchmaker Genomics, a developer and manufacturer of precision reagents for genomics and molecular diagnostics, today announced that it has signed a long-term lease for approximately 100,000 square feet at Flatiron Park in Boulder, Colorado.

PharmaForceIQ Launches Optichannel 360, the First AI-Native Answer-to-Action Engine for Pharma Commercial Teams

PharmaForceIQ has today introduced Optichannel 360, an AI-native commercial execution platform that connects field and digital marketing, including a new measurement answer-to-action workflow.

Symbiosis strengthens commercial team with appointment of Jay Chima

Switchboard Health Acquires Livara Health to Integrate Value-Based Musculoskeletal Care

Allegheny Health Network and The START Center for Cancer Research Announce Strategic Collaboration to Expand Patient Access to Early-Phase Cancer Trials

New START site to be established within AHN Cancer Center will integrate novel oncology research therapies closer to patients across Western Pennsylvania.

Carterra Enables Anthropic's Autonomous AI Protein Design Study via its HT-SPR Binding Platforms

Twist Bioscience and Adaptyv Bio used Carterra HT-SPR platforms to measure 1,320 protein binders against 15 targets designed by Anthropic's Claude models

Inovalon, UST, and AXIOM Systems join 1upHealth’s Partner Program

MEDPHARM EXPANDS END-TO-END PROTEOMIC ANALYSIS CAPABILITIES WITH OLINK® CERTIFICATION

MedPharm has become an Olink® Certified Service Provider (CSP), making it the first Olink CSP in the Carolinas and one of only three in the Southeastern United States. The new capability enables MedPharm to provide Olink proteomic analysis of multi-species samples across a range of matrices, including tissue, plasma, serum and tears, supporting clients from early research through clinical development. The certification expands MedPharm into targeted, multiplex protein biomarker analysis and complements its established disease modeling and human tissue-based research capabilities.

Qureight expands with addition of second site, to accommodate rapid growth and ongoing development of chest Foundation Model

Qureight today announced the opening of its new office space in London, UK. The expansion into a second site will accommodate the Company’s ongoing recruitment and platform technology development, to meet demand for its imaging CRO services across a broader range of lung and heart diseases.

Thomas Scientific Names Jeff Hrush Senior Vice President, Technical Sales

Thomas Scientific today announced that Jeff Hrush has joined the company as Senior Vice President, Technical Sales.

Prescient completes integration of Uptake and Dolon under single global brand

Amprion Partners with MLM Medical Labs to Expand Alpha-Synuclein SAA Testing in Europe

Amprion has announced a strategic licensing collaboration with MLM Medical Labs to expand access to alpha-synuclein seed amplification assay (SAA) testing for biopharma-sponsored clinical trials across Europe. Under the agreement, MLM will validate and perform Amprion's proprietary SAA methodology at its laboratory in Germany, supporting biomarker-driven neurodegenerative disease research and multinational clinical trials. The collaboration is intended to improve patient characterization and accelerate drug development for disorders such as Parkinson's disease, Lewy body dementia, and multiple system atrophy, while further expanding Amprion's international research capabilities.

CPHI launches new Sustainability Summit as pharma faces growing pressure to deliver sustainability goals

Broken String Biosciences launches BaseMap ABE to enable genome-wide off-target characterization in base editing therapeutic development

• Extension of the INDUCE-seq platform to support adenine base editing (ABE) workflows • Researchers invited to gain early access to platform and support ongoing product development

ECI’s Product & Packaging Testing Laboratory Achieves ISO/IEC 17025 Accreditation

ECI announced today that its Product & Packaging Testing Laboratory, located in the Coyol Free Zone in Costa Rica, has achieved ISO/IEC 17025:2017 accreditation from A2LA for technical competence in mechanical testing.

Sanofi’s MenQuadfi Wins EU Approval for Infants from Six Weeks Against Meningococcal Disease

Sanofi’s MenQuadfi has received European Commission approval for use in infants from six weeks of age against invasive meningococcal disease caused by serogroups A, C, W and Y. The expanded indication is supported by the MET58 pivotal study and clinical data involving more than 6,000 infants across 11 countries. The approval provides EU healthcare professionals with another option for early protection against a rapidly progressing and potentially fatal infection.